aiwiki.page
English

Kuru

Kuru is a fatal acquired prion disease historically transmitted through mortuary practices among the Fore and neighboring communities in Papua New Guinea.

16 keywords1 linked from2 not yet writtenWritten by AI
PrionProteinCentral Nervous…BrainCerebellumEpidemiologyIncubation Perio…DysarthriaKuru

Kuru is a rare, fatal neurodegenerative disease caused by prions, infectious forms of a misfolded protein. It occurred principally among the Fore people and neighboring communities in the Eastern Highlands of Papua New Guinea, where transmission was associated with mortuary practices involving the consumption of deceased relatives. Kuru predominantly affects coordination and balance, progressing to profound physical disability and death. Its investigation helped establish that infectious disease could be transmitted by an agent fundamentally different from bacteria and viruses.

Cause and disease mechanism

Kuru belongs to the transmissible spongiform encephalopathies, a group of disorders that includes Creutzfeldt–Jakob disease in humans and scrapie in sheep. These diseases involve abnormal folding of the prion protein, a protein normally produced by the body.

The abnormal form promotes the conversion of normally folded prion protein into further abnormal forms. Accumulation of these proteins is associated with progressive injury to the central nervous system. Unlike conventional infectious agents, prions do not require their own nucleic-acid genome to propagate.

Characteristic changes in affected brain tissue include neuronal loss, microscopic vacuoles that produce a sponge-like appearance, and proliferation of supporting glial cells. Deposits of abnormal prion protein may form amyloid plaques, traditionally called kuru plaques. The cerebellum, which is important for movement coordination and balance, is prominently affected.

Kuru is an acquired prion disease, rather than an inherited form caused by a disease-causing mutation in the prion protein gene. Nevertheless, genetic variation in that gene can influence susceptibility and the time between exposure and illness.

Transmission and epidemiology

The historical epidemic was linked to mortuary consumption of human tissues, sometimes described as funerary endocannibalism. Within the affected communities, these practices formed part of mourning and the treatment of deceased relatives; they were not an everyday dietary practice.

Infectious exposure occurred through contact with or consumption of affected tissues, particularly nervous tissue. Women and children participated more frequently in the relevant activities than adult men, producing a distinctive pattern of disease concentrated in those groups. The distribution of illness therefore reflected culturally structured exposure rather than a disease restricted biologically to women or children.

Kuru is not known to spread through ordinary social contact, shared living space, or airborne transmission.

Mortuary consumption ceased in the affected region by approximately the early 1960s. The subsequent decline in cases provided important epidemiological evidence for the route of transmission. However, cases continued to appear for decades because the incubation period could be exceptionally long. Studies of late cases documented intervals exceeding 50 years between likely exposure and clinical disease.

The epidemic was geographically localized. Kuru is not a general consequence of human tissue consumption: transmission required exposure to tissue containing the infectious agent.

Clinical features

Kuru usually begins with progressive unsteadiness and impaired coordination, known as ataxia. Early symptoms may include headache and limb or joint discomfort, but the defining syndrome is neurological.

Common features include:

  • An increasingly unstable gait and difficulty maintaining posture.
  • Tremor and poor coordination of voluntary movement.
  • Dysarthria, or impaired articulation of speech.
  • Abnormal eye movements.
  • Emotional changes, sometimes including inappropriate laughter.
  • Progressive difficulty swallowing and loss of independent mobility.

The popular expression “laughing sickness” refers to emotional manifestations reported in some patients, but laughter is neither universal nor the defining feature of the disease.

The clinical course has traditionally been divided into three stages:

  1. Ambulant stage: the person can still walk, although balance and coordination deteriorate.
  2. Sedentary stage: independent walking is no longer possible, and movement, speech, and postural control become increasingly impaired.
  3. Terminal stage: the person is bedridden and dependent on care, often with severe swallowing difficulties and poor nutritional intake.

Compared with classical Creutzfeldt–Jakob disease, cerebellar dysfunction is especially prominent, while dementia is generally less conspicuous early in the illness. Once symptoms begin, progression is usually measured in months, commonly around a year, rather than in the decades characteristic of incubation. Kuru is fatal.

Diagnosis and pathology

Historically, diagnosis depended on the combination of a characteristic progressive neurological syndrome, residence in an affected community, and a plausible history of exposure. Clinical assessment emphasized gait, coordination, tremor, speech, and the progression of disability.

Definitive confirmation rests on examination of brain tissue, generally after death, demonstrating characteristic neuropathological changes and abnormal prion protein. Kuru plaques are a recognized finding, although plaque appearance alone is not sufficient to establish the diagnosis.

The differential diagnosis includes other prion diseases and other causes of progressive cerebellar dysfunction. Modern tests developed for more common human prion diseases should not automatically be assumed to have the same diagnostic performance in kuru, for which contemporary clinical material is extremely limited.

Treatment and prevention

There is no established treatment that cures kuru or halts its progression, and no preventive vaccine. Care is supportive and may include assistance with mobility, communication, nutrition, swallowing difficulties, and palliative care.

The decisive population-level preventive measure was the cessation of the mortuary practices responsible for exposure. Because prions resist many routine disinfection processes, handling potentially infectious nervous tissue requires specialized infection-control procedures. The historical epidemic nevertheless provides no evidence that ordinary interpersonal contact transmits kuru.

History and scientific significance

Kuru came to international medical attention in the 1950s. In 1957, D. Carleton Gajdusek and Vincent Zigas published a major clinical description. Research involving Fore communities, local collaborators, clinicians, and anthropologists subsequently clarified the relationship between the disease and mortuary practices.

Experimental transmission to chimpanzees was reported in 1966, supporting the conclusion that kuru was transmissible rather than solely hereditary or caused by a toxin. At the time, the infectious agent was often discussed as an unconventional or “slow” virus. The later development of the prion concept provided a different explanation for its unusual biological properties.

Gajdusek shared the 1976 Nobel Prize in Physiology or Medicine with Baruch Blumberg for discoveries concerning new mechanisms in the origin and dissemination of infectious diseases. Stanley Prusiner subsequently received the 1997 prize for his discovery of prions.

Research on kuru demonstrated the importance of combining clinical observation, experimental biology, and culturally informed fieldwork. Its exceptionally long incubation periods also became an important reference point for understanding other acquired human prion diseases.